tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MNPR Stock Latest News

Monopar Therapeutics downgraded to Hold from Buy at JonesResearch
The FlyMonopar Therapeutics downgraded to Hold from Buy at JonesResearch
4d ago
MNPR
Monopar Therapeutics Inc: Strategic Advancements and Promising Financial Projections Justify Buy Rating
PremiumRatings
Monopar Therapeutics Inc: Strategic Advancements and Promising Financial Projections Justify Buy Rating
5d ago
MNPR
Buy Rating for Monopar Therapeutics Inc: Strategic Advancements and Promising Financial Outlook
PremiumRatings
Buy Rating for Monopar Therapeutics Inc: Strategic Advancements and Promising Financial Outlook
5d ago
MNPR
Monopar Therapeutics sees cash runway through December 31, 2026
PremiumThe Fly
Monopar Therapeutics sees cash runway through December 31, 2026
6d ago
MNPR
Monopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last year
PremiumThe Fly
Monopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last year
6d ago
MNPR
Buy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential
PremiumRatingsBuy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential
18d ago
MNPR
Monopar Therapeutics assumed with an Overweight at Piper Sandler
Premium
The Fly
Monopar Therapeutics assumed with an Overweight at Piper Sandler
18d ago
MNPR
Is MNPR a Buy, Before Earnings?
Premium
Pre-Earnings
Is MNPR a Buy, Before Earnings?
19d ago
MNPR
Monopar Therapeutics Appoints Quan Vu as New CFO
PremiumCompany Announcements
Monopar Therapeutics Appoints Quan Vu as New CFO
1M ago
8K
MNPR
Monopar Therapeutics Appoints Lavina Talukdar to Board
PremiumCompany Announcements
Monopar Therapeutics Appoints Lavina Talukdar to Board
1M ago
8K
MNPR
Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
PremiumThe Fly
Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
2M ago
MNPR
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
PremiumThe Fly
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
3M ago
MNPR
Monopar Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe FlyMonopar Therapeutics initiated with an Overweight at Piper Sandler
3M ago
MNPR
These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025
Premium
Stock Analysis & Ideas
These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025
3M ago
DAVE
MNPR
Monopar Therapeutics prices 798,655 shares at $23.79 in registered offering
Premium
The Fly
Monopar Therapeutics prices 798,655 shares at $23.79 in registered offering
4M ago
MNPR
Monopar Therapeutics Achieves Milestone in Cancer Treatment
PremiumCompany Announcements
Monopar Therapeutics Achieves Milestone in Cancer Treatment
4M ago
8K
MNPR
Monopar Therapeutics doses first patient with MNPR-101-Lu
PremiumThe Fly
Monopar Therapeutics doses first patient with MNPR-101-Lu
4M ago
MNPR
Monopar Therapeutics price target raised to $37 from $9 at JonesResearch
PremiumThe Fly
Monopar Therapeutics price target raised to $37 from $9 at JonesResearch
5M ago
MNPR
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
PremiumThe Fly
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
5M ago
MNPR
Monopar Therapeutics reports Q3 EPS (37c), consensus (48c)
PremiumThe FlyMonopar Therapeutics reports Q3 EPS (37c), consensus (48c)
5M ago
MNPR
Monopar Therapeutics Closes $19.2 Million Stock Offering
Premium
Company Announcements
Monopar Therapeutics Closes $19.2 Million Stock Offering
5M ago
8K
MNPR
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
Premium
The Fly
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
5M ago
MNPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >